Skip Navigation
Department of Health and Human Services www.hhs.gov
  • CME/CE Activities
  • Summary of Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse
 
This website is iPhone friendly.

This CME/CE activity is provided by PRIME Education, Inc. (PRIME®) and is accredited for a multi-disciplinary audience of health care practitioners. This activity is supported by contract number HHSA290201000006G from the Agency for Healthcare Research and Quality. User data collected through this activity will reside on PRIME's educational portal for use by AHRQ.

Summary of Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse

To Receive a Certificate for This Activity:

Course Image
  1. 1. Read the Program Overview on this page.
  2. 2. Review the Faculty Biographies, Accreditation Statements, and Disclosure tabs.
  3. 3. Access the Activity in full.
  4. 4. Complete the Post-Test & Evaluation.
  5. 5. A printable certificate will be available immediately following the activity.

Program Overview

Activity Description

Alcohol misuse is a prevalent disorder affecting all age groups from adolescents to older adults. Misuse may be characterized by risky and hazardous drinking as well as heavy drinking episodes. More than 85,000 deaths per year are attributed to alcohol misuse in the United States. Identified misuse is often treated by behavioral counseling involving multiple interventions and patient education.

In 2011, the Agency for Healthcare Research and Quality (AHRQ) commissioned a systematic review of published studies to study the comparative effectiveness of screening followed by behavioral counseling, with or without referral, for alcohol misuse in primary care settings. This monograph summarizes the key findings of the review and poses potential applications to clinical practice.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Compare the types of screening tools and their use in populations such as adults, college students and pregnant women
  • Evaluate the effectiveness of behavioral interventions (all types) among young adults and college students, older adults and pregnant women
  • Apply the findings of screening, counseling and referral in primary care settings

Target Audience

This CME activity is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, pharmacists and nurses.

Method of Participation

To receive a certificate for this activity, you should:

  • Complete the learner assessment pretest
  • View the entire activity online
  • Complete an online evaluation & post-test
  • Print your certificate online

The estimated time to complete this activity, including review of the materials, is .75 hour.

Term of Approval

July 31, 2012 through July 30, 2014. Original release date: July 31, 2012

Acknowledgement of Support

There is no fee for this CME/CE activity. This activity is sponsored by PRIME Education, Inc (PRIME®) and funded under contract HHSA290201000006G from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services (HHS).

Faculty Biographies and Disclosures

Click faculty name to view full biography.

Speaker

James C Garbutt, MD
Professor and Medical Director of the Alcohol & Substance Abuse Program
University of North Carolina Department of Psychiatry
Chapel Hill, NC

Planner

Carolyn LePage, PhD, ARNP
Assistant Professor
Barry University School of Nursing
Miami Shores, FL

Planner

Heidi Wynn Maloni, PhD, ANP-BC
National Clinical Nursing Director
Department of Neurology
Multiple Sclerosis Center of Excellence, East
Veterans Affairs Medical Center
Adjunct Faculty
Trinity Nursing Program School of Professional Studies
Trinity Washington University
Clinical Preceptor and Instructor
Advanced Practice Programs
The Catholic University of America School of Nursing
Washington, DC

Planner

Michele B Kaufman, PharmD, B Pharm, RPh
President
PRN Communications, Inc
Clinical Pharmacist
New York Downtown Hospital
New York, NY

Peer Reviewer

Debbie DeMuria, PharmD, RPh
Clinical Pharmacist
Consultant, Regulatory Affairs
Southborough, MA

Peer Reviewer

Frank L Urbano, MD, FACP
Medical Director, Care Management
Albert Einstein Medical Center
Philadelphia, PA
Assistant Professor of Medicine
Cooper Medical School of Rowan University
Camden, NJ

Peer Reviewer

Joyce M Knestrick, PhD, CRNP, FAANP
Coordinator of Graduate Education
Frontier School of Midwifery and Family Nursing
Certified Family Nurse Practitioner
The Primary Care Center
Mt Morris, PA

Peer Reviewer

Kathleen A Jarvis, MS, RN, CCM
Clinical Educator
Alere Healthcare
Fort Lauderdale, FL

Begin Activity

Accreditation/Credit Designation

Physician Credit Designation Statement

A C C M E Logo

PRIME Education, Inc. (PRIME®) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

PRIME® designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of .75 hours of Category I credit for completing this program.

Nurse Practitioner Accreditation Statement

Nurse Practitioner Logo

PRIME Education, Inc (PRIME®) is approved as a provider of Nurse Practitioner Continuing Education by the American Association of Nurse Practitioners. Provider number: 060815. This program is accredited for .75 contact hour. Program ID# CER41.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Pharmacist Accreditation StatementA C P E Logo

This curriculum has been approved for .75 contact hour (0.075 CEUs) by PRIME®. PRIME® is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this program is 0255-0000-12-032-H05-P. This learning activity is Knowledge-Based.

Nurse Accreditation StatementA N C C Logo

PRIME Education, Inc. (PRIME®) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

PRIME® designates this activity for .75 contact hour.

Begin Activity

Faculty Disclosures

Faculty Name
Advisory Board Consultant Grants / Research Salary / Contractual Supported Promotional Education Stock / Shareholder Other Financial Support
James C Garbutt, MD
Planner
None None None None None None None
Carolyn LePage, PhD, ARNP
Planner
None None None Barry University None None None
Heidi Wynn Maloni, PhD, ANP-BC
Planner
sanofi-aventis None None None None None None
Michele B Kaufman, PharmD, B Pharm, RPh
Planner
None OrthoMcNeil Janssen None None None None None
Debbie DeMuria, PharmD, RPh
Reviewer
None Millennium Pharmaceuticals, Inc None None None None None
Frank L Urbano, MD, FACP
Reviewer
None None None None None None None
Joyce M Knestrick, PhD, CRNP, FAANP
Reviewer
None None None None None None None
Kathleen A Jarvis, MS, RN, CCM
Reviewer
None None None None None None None
Chris R Prostko, PhD
Scientific Program Director
NoneNoneNonePRIME®NoneNoneNone
Lynn Goldenberg, RN, BSN
Director of Accreditation & Compliance
NoneNoneNonePRIME®NoneNoneNone

Disclosure Policy

PRIME Education Inc (PRIME®) endorses the standards of the ACCME, as well as those of the AANP, ANCC and ACPE, that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

PRIME® willidentify, review and resolve all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for speakers, authors, course directors, planners, peer reviewers, and/or relevant staff are provided with this activity.

Presentations that provide information in whole or in part related to non FDA approved uses of drugs and/or devices will disclose the unlabeled indications or the investigational nature of their proposed uses to the audience. Participants should refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Participants should verify all information and data before treating patients or employing any therapies prescribed in this educational activity. The opinions expressed in the educational activity are those of the presenting faculty and do not necessarily represent the views of PRIME®, the ACCME, AANP, ACPE, ANCC and other relevant accreditation bodies.

Content validation methods are consistently utilized by PRIME® to ensure that all program content is evidence-based, fair-balanced, and developed with scientific rigor and integrity. All clinical recommendations are based on evidence accepted within the medical profession. All scientific research referred to, reported or used to support a clinical recommendation conforms to accepted standards of experimental design, data collection and analysis. In addition to review of content by course directors and expert faculty, content is also validated through independent peer reviewers selected for their expertise in the content area, as well as their experience in the intended audience. All peer reviewers, planners, course directors, faculty and relevant staff utilized by PRIME® complete disclosures which are related to their role in the educational activity.

Accessibility

PRIME®is committed to providing access to our CME programs for individuals with disabilities as identified in Section 508 of the Rehabilitation Act for all web-based programs. This website is 508 compliant.

Begin Activity

Pretest

To access the activity, please complete this brief Pretest.

  • Returning user? Login Here!
  1. Before accessing this educational activity, were you aware of the AHRQ-supported comparative effectiveness research on screening, behavioral counseling, and referral in primary care to reduce alcohol misuse?

  2. Which of the following most accurately describes alcohol dependence?

  3. Which of the following accurately describes the average alcohol consumption for drinkers who may experience significantly increased mortality relative to nondrinkers?

  4. How would you describe your current level of confidence in applying comparative effectiveness research on screening, behavioral counseling, and referral in primary care to reduce alcohol misuse?

  5. How valuable is comparative effectiveness research on screening, behavioral counseling, and referral in primary care to reduce alcohol misuse in making patient-centered treatment and management decisions?

  6. If you had a clinician summary/consumer summary on screening, behavioral counseling, and referral in primary care to reduce alcohol misuse what would you most likely do?

  7. Rockie, an older adult, presents to the primary care (PC) physician for an unrelated medical issue. Upon taking a patient history, the doctor suspects that Rockie may be engaged in alcohol misuse. In the PC environment, the physician performs a screening and assessment for alcohol misuse which identifies Rockie as a person who is engaged in risky or hazardous use of alcohol. Which subsequent steps may be most appropriate for the doctor to take in order to address Rockie’s hazardous use of alcohol?

Post-Test & Evaluation

You must access the activity before receiving credit!